Skip to main content
. 2024 Oct 14;7:280. doi: 10.1038/s41746-024-01293-4

Table 5.

Therapy details

Gross Tumor Volume (GTV) [cm³] Median (range) 21 (2.2–383)
Planning Target Volume (PTV) [cm³] Median (range) 37 (5.1–517)
PTV margin expansion [mm] Median (range) 3 (3–6)
Numbers of Fractions Median (range) 5 (3–5)
3 fractions, N (%) 10 (21%)
5 fractions, N (%) 38 (79%)
BED10 [Gy] Median (range) 72 (43–112)
3 Fractions
Prescription Dose [Gy] Median (range) 40.5 (24–45)
BED10 [Gy] Median (range) 95 (43–112)
PTVopt Dmax [Gy] Median (range) 62 (31–75)
5 Fractions
Prescription Dose [Gy] Median (range) 40 (30–50)
BED10 [Gy] Median (range) 72 (48–100)
PTVopt Dmax [Gy] Median (range) 49 (32–68)
Conformity Index (CI) Median (range) 0.98 (0.39–1.39)
Homogeneity Index (HI) Median (range) 1.25 (1.05–1.86)
Number of adapted fractions Median (range) 4 (0–5)
Respiratory Motion Management Technique
Deep inspiration breath hold (DIBH) N (%) 39 (81%)
Deep expiration breath hold (DEPH) N (%) 7 (15%)
Free breathing N (%) 2 (4%)